SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 60 filers reported holding SPERO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $105,000 | -49.0% | 12,015 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $206,000 | -15.6% | 12,860 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $244,000 | +29.1% | 13,245 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $189,000 | +8.0% | 13,559 | +13.8% | 0.00% | 0.0% |
Q1 2021 | $175,000 | -23.9% | 11,916 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $230,000 | +132.3% | 11,885 | +34.4% | 0.00% | – |
Q3 2020 | $99,000 | -16.8% | 8,840 | +0.4% | 0.00% | -100.0% |
Q2 2020 | $119,000 | +91.9% | 8,802 | +15.4% | 0.00% | – |
Q1 2020 | $62,000 | -7.5% | 7,626 | +8.9% | 0.00% | – |
Q4 2019 | $67,000 | -8.2% | 7,003 | +1.7% | 0.00% | – |
Q3 2019 | $73,000 | -2.7% | 6,888 | +5.7% | 0.00% | – |
Q2 2019 | $75,000 | +15.4% | 6,514 | +28.1% | 0.00% | – |
Q1 2019 | $65,000 | +91.2% | 5,084 | -8.4% | 0.00% | – |
Q4 2018 | $34,000 | -42.4% | 5,548 | -0.8% | 0.00% | – |
Q3 2018 | $59,000 | -7.8% | 5,591 | +28.7% | 0.00% | – |
Q2 2018 | $64,000 | +16.4% | 4,345 | +12.7% | 0.00% | – |
Q1 2018 | $55,000 | +14.6% | 3,857 | -5.1% | 0.00% | – |
Q4 2017 | $48,000 | – | 4,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |